Category: response
HUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab)
HUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In combin
View DetailsENBREL 10 MG PEDIA INJ FL + SRG + NEC (Etanercept)
ENBREL 10 MG PEDIA INJ FL + SRG + NEC (Etanercept) - Maladie rare sans désignation orpheline *Tre
View DetailsENBREL 25 MG INJ FL + SRG + NEC (Etanercept)
ENBREL 25 MG INJ FL + SRG + NEC (Etanercept) - Maladie rare sans désignation orpheline *Treatment
View DetailsENBREL 25 MG INJ FL + SRG 0,5 ML + NEC (Etanercept)
ENBREL 25 MG INJ FL + SRG 0,5 ML + NEC (Etanercept) - Maladie rare sans désignation orpheline *Tr
View DetailsENBREL 25 MG/ML PEDIA FL + SRG + NEC (Etanercept)
ENBREL 25 MG/ML PEDIA FL + SRG + NEC (Etanercept) - Maladie rare sans désignation orpheline *Trea
View DetailsENBREL 50 MG INJ FL + SRG + NEC (Etanercept)
ENBREL 50 MG INJ FL + SRG + NEC (Etanercept) - Maladie rare sans désignation orpheline *Treatment
View DetailsENBREL 50 MG INJ FL (Etanercept)
ENBREL 50 MG INJ FL (Etanercept) - Maladie rare sans désignation orpheline *Treatment of polyarth
View DetailsENBREL 50 MG INJ SRG 1 ML + NEC (Etanercept)
ENBREL 50 MG INJ SRG 1 ML + NEC (Etanercept) - Maladie rare sans désignation orpheline *Treatment
View DetailsENBREL 50 MG INJ STY 1 ML + TAMP (Etanercept)
ENBREL 50 MG INJ STY 1 ML + TAMP (Etanercept) - Maladie rare sans désignation orpheline *Treatmen
View Details